共 50 条
- [31] THE RELATIVE BENEFIT AND RISKS OF INTRAVENOUS STREPTOKINASE AND TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION RISK/BENEFIT ANALYSIS FOR THE USE AND APPROVAL OF THROMBOLYTIC, ANTIARRHYTHMIC, AND HYPOLIPIDEMIC AGENTS, 1989, : 23 - 28
- [34] ENDOGENOUS TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND RISK OF MYOCARDIAL-INFARCTION LANCET, 1993, 341 (8854): : 1165 - 1168
- [39] HEMORRHAGIC COMPLICATIONS ASSOCIATED WITH THE USE OF INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR IN TREATMENT OF ACUTE MYOCARDIAL-INFARCTION AMERICAN JOURNAL OF MEDICINE, 1988, 85 (03): : 353 - 359
- [40] CARDIAC MORPHOLOGIC FINDINGS IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION TREATED WITH RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (15): : 953 - 961